Investigating cancer treatment approaches at Fred Hutchinson Cancer Center
Official title: Core-002
Funded at Fred Hutchinson Cancer Center · NIH-11231827 · Data updated 2026-11-12
This study is looking for new and better ways to treat cancer, and if you're a patient, you might have the chance to join in and help test these exciting new treatments!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | January 30, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $432,572 |
| NIH project number | 5U19AI174242-03 |
| Project ID | NIH-11231827 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would include individuals diagnosed with various types of cancer who are seeking new treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those who are not eligible for clinical trials may not receive any benefit from this research.
What this research studies
This research focuses on exploring innovative methods for cancer treatment at the Fred Hutchinson Cancer Center. The team, led by Principal Investigator Leonidas Stamatatos, aims to develop and test new therapeutic strategies that could improve patient outcomes. By leveraging advanced technologies and collaborative efforts, the research seeks to enhance our understanding of cancer biology and treatment efficacy. Patients may have the opportunity to participate in clinical trials that evaluate these novel approaches.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved survival rates for patients.
How similar studies have gone: Previous research at Fred Hutchinson Cancer Center has shown success in developing innovative cancer therapies, indicating a strong potential for impactful findings in this area.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Stamatatos, Leonidas — Fred Hutchinson Cancer Center
- Study coordinator: Stamatatos, Leonidas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.